sold out the other day after more than 800 days holding (I double checked out of curiosity).
will keep an eye on it, but not even thinking about reentering until they are actually treating utis in their trial, or the ceo actually starts giving clear description of their required clinical plans and the status of their current trials.
read the latest analyst report on their website and it has a bunch of stuff that makes sense. but I have heard none of it come from their own ceo.
tbh this interview was basically rambling.
sold out the other day after more than 800 days holding (I...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $83.62M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 29.0¢ | $24.34K | 81.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 21086 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 2018 | 1 |
View Market Depth
| Last trade - 11.03am 19/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |